Cat. No.: X23-10-ZQ799
PKC inhibitor LY317615, Purity ≥98%
Synonym: Enzastaurin; 170364-57-5; LY317615; Enzastaurin (LY317615); 3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione; LY-317615; 3-(1-Methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione; PKC inhibitor
- MDL: MFCD11040980
- CAS Number: 170364-57-5
- Compound CID: 176167
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Properties
Description
LY317615, soluble in DMSO and insoluble in ethanol and water, acts as an ATP-competitive PKC inhibitor. It targets PKCα, PKCβ, PKCε, and PKCγ.
Molecular Formula
C32H29N5O2
Targets
PKCα: 39 nM; PKCβ: 6 nM; PKCε: 110 nM; PKCγ: 83 nM
Solubility
DMSO: 29 mg/mL (56.24 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY317615 can be used to study its inhibitory effects on PKCβ and its potential therapeutic applications in diabetes-related complications and cancer.
Related Products
Quick Links
